Caliber Advisors has been retained by some of the most prominent pharmaceutical and biotechnology companies in the world in important corporate transactional matters and intercompany transactions. Our practice ranges from emerging drug discovery companies to large, global pharmaceutical firms. Of critical importance in this field is understanding the strength of the underlying science and patent protections, competitive treatments, the drug development process, Medicare reimbursement rates, insurance coverage, marketing costs and more. Our years of expertise in this industry provides us with the skill sets necessary to achieve successful outcomes for our clients.
Practice highlights include provisioning:
- Fairness opinions
- Valuation opinions for cheap stock issuance in compliance with ASC 718, 820 and IRC 409a
- Intangible asset and In-process R&D valuation for GAAP purposes (ASC 805 and IFRS 3)
- Transfer pricing analysis under IRC Section 1.482